SuicidalitySchizophreniaSafety & Risk ManagementLSD

Neurotoxicity and LSD treatment: a follow-up study of 151 patients in Denmark

This historic archive case study assessed the reports of 151 patients out of a 400 patient cohort who received treatment with LSD between 1960-73 (without psychotherapy) and who received financial compensation for LSD-inflicted harm in accordance with Danish law. The applicants reported an immediate deterioration of their condition and severe long-term effects.

Authors

  • Larsen, J. K.

Published

History of Psychiatry
individual Study

Abstract

LSD was introduced in psychiatry in the 1950s. Between 1960 and 1973, nearly 400 patients were treated with LSD in Denmark. By 1964, one homicide, two suicides and four suicide attempts had been reported. In 1986 the Danish LSD Damages Law was passed after complaints by only one patient. According to the Law, all 154 applicants received financial compensation for LSD-inflicted harm. The Danish State Archives has preserved the case material of 151 of the 154 applicants. Most of the patients suffered from severe side effects of the LSD treatment many years afterwards. In particular, two-thirds of the patients had flashbacks. With the recent interest in LSD therapy, we should consider the neurotoxic potential of LSD.

Available with Blossom Pro

Research Summary of 'Neurotoxicity and LSD treatment: a follow-up study of 151 patients in Denmark'

Introduction

Larsen frames the study against the historical backdrop of LSD's introduction into psychiatry in the 1950s and its rapid uptake at research and clinical centres in Scandinavia. Early enthusiasm for LSD as an aid to psychotherapy and as a model psychosis coexisted with sporadic reports of serious adverse events, including homicide, suicide and persistent perceptual disturbances. Debate about the long-term safety of clinical LSD use persisted into the 1970s; in Denmark, preserved case material and later political and legal activity culminated in the 1986 LSD Damages Law, which allowed treated patients to apply for compensation under a reversed burden of proof (treatment deemed the cause of harm unless another cause was more likely). This paper sets out to use the case records held in the Danish State Archives to evaluate long-term outcomes after LSD treatment in Denmark. Larsen aimed to describe both potential benefits and harms decades after exposure, and specifically to seek evidence bearing on the alleged neurotoxic potential of LSD by analysing the case material of patients who had applied for compensation under the 1986 law.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (7)

Papers cited by this study that are also in Blossom

Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles

Tracy, D., Baumeister, D., Barnes, G. et al. · Therapeutic Advances in Psychopharmacology (2014)

Lysergic acid diethylamide: side effects and complications

Cohen, S. · Journal of Nervous and Mental Disease (1980)

Flashback: psychiatric experimentation with LSD in historical perspective

Dyck, E. · Canadian Journal of Psychiatry (2005)

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

Gasser, P., Holstein, D., Michel, Y. et al. · Journal of Nervous and Mental Disease (2014)

594 cited
Hallucinogen persisting perception disorder: what do we know after 50 years?

Halpern, J. H., Pope Jr, H. G. · Drug and Alcohol Dependence (2003)

204 cited
The pharmacology of lysergic acid diethylamide: a review

Passie, T., Halpern, J. H., Stichtenoth, D. O. et al. · CNS Neuroscience and Therapeutics (2008)

Adverse Reactions to Psychedelic Drugs - A Review of the Literature

Strassman, R. J. · Journal of Nervous and Mental Disease (1984)

273 cited

Cited By (9)

Papers in Blossom that reference this study

Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis

Hinkle, J. T., Graziosi, M., Nayak, S. et al. · JAMA Psychiatry (2024)

84 cited
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences

Zeifman, R. J., Kettner, H., Pagni, B. A. et al. · Scientific Reports (2023)

22 cited
Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder

Ledwos, N., Rodas, J. D., Husain, M. I. et al. · Journal of Psychopharmacology (2022)

Psychedelic-Assisted Therapy for People with Eating Disorders

Gukasyan, N., Schreyer, C. C., Griffiths, R. R. et al. · Current Psychiatry Reports (2022)

Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States

Davis, A. K., Agin-Liebes, G. I., España, M. et al. · Journal of Psychoactive Drugs (2021)

Psychedelics and the essential importance of context

Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)

Psychiatry & the psychedelic drugs. Past, present & future

Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.